This formula combines a comprehensive array of studied peptide complexes (described below) to target multiple signs of aging.
Matrixyl™ aims to reduce the look of static and dynamic wrinkles. This complex contains two generations of Matrixyl™: Matrixyl™ 3000 (with palmitoyl tetrapeptide-7) and Matrixyl™ synthe'6 (palmitoyl tripeptide-38). ARGIRELOX™ (with acetyl hexapeptide-8 and pentapeptide-18) aims to improve the appearance of facial areas prone to developing dynamic folds, including around the eyes and in the forehead area. SYN™-AKE (with dipeptide diaminobutyroyl benzylamide diacetate) targets the look of dynamic wrinkles.
Relistase peptide complex (with acetylarginyltryptophyl diphenylglycine) aims to improve visible signs of aging, such as loss of skin elasticity, and providing structural support to the skin.
The formula is further supported by the inclusion of a probiotic complex (with lactococcus lactis lysate), a base of 11 skin-friendly amino acids, and multiple hyaluronic acid complexes. The total concentration of these technologies in the formula by weight is 25.1%.
References are made to third-party trademarks in this description. SYN™ is a trademark of DSM, Matrixyl™ synthe'6™ and Matrixyl™ 3000 are trademarks of Sederma Inc., and ARGIRELOX™ is a trademark of Lipotec S.A.U. Neither The Ordinary nor DECIEM is affiliated with these trademarks or their owners.